Skip to Content

A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL) [Location: Pierre]

Principal Investigator(s)
Roberto Ferro, MD

Clinical Trial Categories

  • Leukemia
Hematology Research Coordinators at 605-322-3090
How to Participate

Clinical Trial Details »


  • Avera Cancer Institute at Pierre
    801 E. Sioux Ave.
    Pierre, SD 57501
    Main: 605-224-3370
    Fax: 605-224-3296

Moving Health Forward

Avera is a health ministry rooted in the Gospel. Our mission is to make a positive impact in the lives and health of persons and communities by providing quality services guided by Christian values.

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.